Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis
Natalia Mena‐Vázquez, Francisco Javier Godoy‐Navarrete, Sara Manrique‐Arija, María Carmen Aguilar-Hurtado, Carmen María Romero-Barco, Inmaculada Ureña‐Garnica, Francisco Espíldora, Isabel Añón‐Oñate, Lorena Pérez-Albaladejo, Carmen Gomez-Cano, Francisco Gabriel Jiménez-Núñez, María Isabel Padin-Martín, Antonio Fernández‐Nebro
Topics & Concepts
MedicineInternal medicineTocilizumabRheumatoid arthritisInterstitial lung diseaseRheumatologyAbataceptAdverse effectRituximabTNF inhibitorPulmonary function testingEtanerceptLungLymphomaInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisRheumatoid Arthritis Research and TherapiesSarcoidosis and Beryllium Toxicity Research